Oral cancer prevention advances with a translational trial of green tea.

Abstract

This perspective on Tsao et al. (beginning on p. 931 in this issue of the journal) discusses green tea extract, which was shown for the first time to have dose-dependent effects in a clinical chemopreventive setting (oral premalignant lesions). This translational trial provides important data on angiogenesis and other biomarkers on which to base future clinical research, which should include trials of green tea extract or polyphenols combined with other natural or synthetic compounds to enhance chemopreventive effects.

• Authors: Dong M Shin
• Journal: Cancer prevention research (Philadelphia, Pa.) (Cancer Prev Res (Phila)) Vol. 2 Issue 11 Pg. 919-21 (Nov 2009) ISSN: 1940-6215 [Electronic] United States
• PMID: 19892661 (Publication Type: Comment, Journal Article)

Chemical References

• Plant Extracts
• Tea

Topics

• Humans
• Mouth Neoplasms (prevention & control)
• Phytotherapy
• Plant Extracts (therapeutic use)
• Precancerous Conditions (prevention & control)
• Tea
• Treatment Outcome